Selling a regulated health product in the Philippines without registration is not a paperwork gap. It is a prohibited act under Republic Act No. 9711, the Food and Drug Administration Act of 2009, punishable by imprisonment of one to ten years, a fine of PHP 50,000 to PHP 500,000, or both, with separate administrative fines and cease and desist authority available to the agency. That is the risk sitting behind every unregistered SKU on a shelf, in a warehouse, or listed on a marketplace.
The document that removes that risk is the FDA Certificate of Product Registration (CPR). An FDA CPR is the marketing authorization that confirms a specific product, in a specific formulation and presentation, may lawfully be manufactured, imported, distributed, or sold in the country. It is granted per product, not per company, and not per brand.
What most importers and manufacturers get wrong is sequence and scope. The certificate cannot be applied until the company itself is licensed; it does not cover all products regulated by the Food and Drug Administration, and the rules on validity and fees have changed materially under Administrative Order No. 2024-0016, signed on 9 December 2024. Companies still budgeting on two-year registrations and old fee tables are planning against a framework that no longer exists.
Two different authorizations govern regulated health products, and they operate at different levels. The License to Operate is the company-level permit. It authorizes the establishment, whether manufacturer, trader, importer, exporter, distributor, or retailer, to engage in the business at all. The FDA CPR is the product-level authorization. It attaches to the item.
Neither substitutes for the other. A licensed importer with no product registration cannot lawfully bring in the goods. A registered product whose holder allows the license to lapse loses its regulatory footing. Customs release, retailer accreditation, marketplace listing approval, government procurement, and public bidding all depend on presenting current documentation for both.
The certificate is also narrower than most applicants expect. Registration covers the product as filed. Variants, dosage strengths, flavors, and packaging presentations are treated separately, so a product line generates a portfolio of certificates rather than a single one. A change to formulation or labeling requires a variation filing or, depending on the extent of the change, a fresh application.
Most rejected or stalled applications fail on one of four points. Each is manageable, and each is expensive to fix after filing.
The License to Operate is the prerequisite, not a parallel workstream. Under Administrative Order No. 2016-0003, the unified licensing framework, establishments must hold the appropriate license before engaging in any regulated activity, and an initial license is valid for 2 years, while a renewal is valid for 5.
Initial license requirements typically include:
Renewal applications should be filed within three months before the validity date. Filing after expiration triggers surcharges under Republic Act No. 9711 and its implementing rules.
Not every regulated product travels the registration route, and filing under the wrong pathway wastes both the fee and the processing time.
Getting this classification right at the outset determines the dossier, the evaluating center, the fee, and the timeline.
The Food and Drug Administration evaluates completeness first and substance second. An incomplete filing is returned rather than assessed, which restarts the clock without refunding the effort.
A typical initial application package includes:
Renewal filings are lighter, generally requiring the application form, proof of payment, current labels for each packaging size, and documentation of any changes made since the last approval.
This is where the 2024 reform changed the arithmetic. Administrative Order No. 2024-0016 prescribes a new schedule of fees and charges and, alongside it, longer registration validity periods:
Fees are now expressed as an annual rate and multiplied by the number of years of validity selected. The order’s own worked example is a high-risk food product with a three-year validity at PHP 3,500 per year, producing PHP 10,500 plus PHP 105 for the Legal Research Fee. That fee, imposed under Republic Act No. 3870 as amended, is PHP 10 or one percent of the application fee, whichever is higher, and the agency collects it as an agent rather than for its own account. Fees are subject to review every two years, so the order of payment generated by the system, not a cached fee table, is the figure that governs.
The single most expensive mistake in product registration is treating the expiry date as a soft deadline. The implementing rules of Republic Act No. 9711, reiterated in Administrative Order No. 2024-0016, set a strict penalty structure for late renewal.
Automatic renewal is available, but only under certain conditions. The application must be filed before the expiration date, the prescribed renewal fee must be paid on filing, and a sworn statement must confirm that there has been no change or variation whatsoever in the product. Any change, however minor, removes the product from that route.
A registration review is warranted whenever any of these apply:
Handled well, registration does more than avoid enforcement:
Registration in the Philippines is a highly technical transaction, and Republic Act No. 11032, the Ease of Doing Business and Efficient Government Service Delivery Act of 2018, caps prescribed processing time for highly technical transactions at twenty working days, extendable once, with the clock starting only from receipt of a complete application. That last clause is the operative one. Completeness, not persistence, is what accelerates a file.
The agency has also moved its transactions online. Applications run through the ePortal and the eServices platform, with Circular No. 2025-006 establishing centralized online user account registration and renewal across the ePortal, ePortal2, and RRD Portal, replacing the earlier manual account processes. Approved authorizations can be checked through the agency’s public verification site. The practical consequence is that most delays are now attributable to dossier quality rather than queueing.
An FDA CPR is a product-level marketing authorization that can only be obtained by an establishment already holding a valid License to Operate, and it covers only the product as registered, with separate filings for each variant, strength, flavor, and packaging presentation. Cosmetics run through notification instead, and medical devices through their own notification or registration certificates, so classifying the product correctly is the first substantive decision an applicant makes.
Administrative Order No. 2024-0016 reset both the economics and the calendar. Validity now runs three or six years for food, six years for drugs and devices, and six or twelve years for household and urban pesticides and hazardous substances, with fees charged at an annual rate multiplied by the validity chosen plus the Legal Research Fee. Renewal discipline is what protects that investment: file before expiry with a sworn statement of no change, and the renewal is straightforward; file late, and the cost is double the renewal fee plus ten percent per month; and file more than 120 days after expiry, and the product starts over as a new application.
Yes, Business Registration Philippines delivers complete, end-to-end registration and compliance management as a trusted specialist, ensuring your corporation is legally operational in weeks, not months, after filing. Our proven expertise turns regulatory complexity into an immediate competitive advantage. Reach out today to schedule an initial consultation with one of our experts: